Ribi ImmunoChem deal

RIBI (Hamilton, Mont.) finalized a previously announced co-exclusive license and supply agreement with American Cyanamid's Lederle-Praxis Biologicals division.

Cyanamid received a worldwide license to use RIBI adjuvants. Prophylactic vaccines in the agreement include pertussis, Haemophilus influenzae and Streptococcus pneumoniae as well as other specified bacterial and viral diseases. ...